Zhiqi Feng
State Key Laboratory Of Natural Medicines, Jiangsu Provincial University Key Laboratory Of Drug Discovery For Metabolic Inflammatory Diseases
Nanjing, 210009, China
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Design, synthesis, and biological evaluation of aryl urea derivatives as novel STING inhibitors based on SN-011.
Journal: Bioorganic & medicinal chemistry
Published: May 25, 2026
Design, Synthesis, and Biological Evaluation of Arylimidazole Derivatives as Potent PPARδ Agonists for the Treatment of Renal Fibrosis.
Journal: Journal of medicinal chemistry
Published: February 10, 2026
Discovery of indane and naphthalene derivatives as USP7 inhibitors.
Journal: European journal of medicinal chemistry
Published: April 24, 2025
Design, synthesis, and Biological evaluation of novel macrocyclic derivatives as potent ATP-citrate lyase inhibitors.
Journal: European journal of medicinal chemistry
Published: February 28, 2025
Discovery of an Orally Bioavailable STING Inhibitor with In Vivo Anti-Inflammatory Activity in Mice with STING-Mediated Inflammation.
Journal: Journal of medicinal chemistry
Published: January 28, 2025
Design, synthesis, and biological evaluation of imidazolidinone derivatives as potent PPARα/δ agonists for the treatment of cholestatic liver diseases.
Journal: European journal of medicinal chemistry
Published: December 10, 2024
Discovery of Novel PD-L1 Small-Molecular Inhibitors with Potent In Vivo Anti-tumor Immune Activity.
Journal: Journal of medicinal chemistry
Published: March 11, 2024
Design, synthesis, and biological evaluation of piperazine derivatives as pan-PPARs agonists for the treatment of liver fibrosis.
Journal: European journal of medicinal chemistry
Published: February 20, 2024
Discovery of the First Subnanomolar PPARα/δ Dual Agonist for the Treatment of Cholestatic Liver Diseases.
Journal: Journal of medicinal chemistry
Published: May 27, 2023
Discovery of novel AdipoRon analogues as potent anti-inflammatory agents against nonalcoholic steatohepatitis.
Journal: European journal of medicinal chemistry
Published: June 30, 2022
Design, Synthesis, and Biological Evaluation of Triazolone Derivatives as Potent PPARα/δ Dual Agonists for the Treatment of Nonalcoholic Steatohepatitis.
Journal: Journal of medicinal chemistry
Published: January 21, 2022
Discovery of Novel Peroxisome Proliferator-Activated Receptor α (PPARα) Agonists by Virtual Screening and Biological Evaluation.
Journal: Journal of chemical information and modeling
Published: February 07, 2020
Last Updated: 09/26/2026